Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

LOPERAMIDE OXIDE MONOHYDRATE CRS (20 MG)

LOPERAMIDE OXIDE MONOHYDRATE CRS (20 MG)

106900-12-3

DISCOVER
Testosterone for impurity D identification

Testosterone for impurity D identification

58-22-0

DISCOVER
Testosterone for system suitability

Testosterone for system suitability

58-22-0

DISCOVER
Temazepam impurity C CRS, 5mg

Temazepam impurity C CRS, 5mg

18818-64-9

DISCOVER
Temazepam impurity D CRS, 5mg

Temazepam impurity D CRS, 5mg

17191-70-7

DISCOVER
Temazepam impurity F CRS, 10mg

Temazepam impurity F CRS, 10mg

3294-96-0

DISCOVER
Temazepam impurity G CRS, 5mg

Temazepam impurity G CRS, 5mg

93329-92-1

DISCOVER
INSULIN LISPRO CRS (6 MG)

INSULIN LISPRO CRS (6 MG)

133107-64-9

DISCOVER
INSULIN ASPART CRS (8 MG)

INSULIN ASPART CRS (8 MG)

116094-23-6

DISCOVER
OXELADIN HYDROGEN CITRATE CRS(40 MG)

OXELADIN HYDROGEN CITRATE CRS(40 MG)

52432-72-1

DISCOVER
BECLOMETASONE  DIPROPIONATE MONOHYDRATE CRS (10 MG)

BECLOMETASONE DIPROPIONATE MONOHYDRATE CRS (10 MG)

08/09/5534

DISCOVER
BECLOMETASONE  DIPROPIONATE FOR SYSTEM SUITABILITY CRS (15 M

BECLOMETASONE DIPROPIONATE FOR SYSTEM SUITABILITY CRS (15 M

08/09/5534

DISCOVER